Danish manufacturer Coloplast increased the transvaginal mesh litigation provision in its budget by 3 billion Danish crowns ($448 million).
The provision is set aside to cover settlement and legal costs in the U.S. More than 2,000 lawsuits against Coloplast are pending in a multidistrict litigation court in the Southern District of West Virginia.
“We have been ordered by the judicial system in the U.S. to take preliminary steps towards actual litigation on 200 specific cases,” Coloplast president and CEO Lars Rasmussen said in a press release. “This means that our costs in relation to the litigation will increase.
